Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients With Primary Central Nervous Lymphoma (PCNSL)

NCT00727831 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00727831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00727831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Escalating High Dose Methotrexate Supported by Glucarpidase to Treat Patients With Primary Central Nervous Lymphoma (PCNSL)
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2008
Completion date
July 31, 2011
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic agent toxicity, lymphoma, mucositis, neurotoxicity